Table 1.
Descriptive characteristics of IDEA SSP clients at baseline and follow-up timepoints (N=115).
| Characteristic | Baseline (n,%) | 1st Follow-up (n,%) | 2nd Follow-up (n,%) |
|---|---|---|---|
| Age (median, IQR) | 38 (32–47) | --- | --- |
| Biological Sex | |||
| Male | 88 (76.5) | --- | --- |
| Female | 27 (23.5) | --- | --- |
| Race/Ethnicity | |||
| Non-Hispanic White | 57 (50.4) | --- | --- |
| Non-Hispanic Black | 5 (4.4) | --- | --- |
| Hispanic | 51 (45.1) | --- | --- |
| Housing Status | |||
| Currently experiencing homelessness | 56 (58.3) | 63 (56.3) | 59 (57.3) |
| Drugs Injected | |||
| Heroin | 97 (84.4) | 95 (84.8) | 69 (66.4) |
| Cocaine | 30 (26.1) | 31 (27.7) | 41 (39.4) |
| Methamphetamine | 10 (8.7) | 8 (7.1) | 10 (9.6) |
| Crack-cocaine | 11 (9.6) | 19 (17.0) | 20 (19.2) |
| Speedball | 25 (21.7) | 34 (30.4) | 34 (32.7) |
| Fentanyl | 17 (14.8) | 28 (25.0) | 43 (41.4) |
| HIV-positive | 11 (9.7) | 18 (17.1) | 18 (17.1) |
| HCV-positive | 50 (45.1) | 60 (58.2) | 64 (62.1) |
| Average number of injections per day | |||
| <5 | 64 (57.7) | 58 (53.2) | 47 (48.0) |
| ≥5 | 47 (42.3) | 51 (46.8) | 51 (52.0) |
| Injection in public places (e.g. streets) | |||
| Yes | 64 (55.7) | 71 (63.4) | 57 (54.8) |
| No | 51 (44.3) | 41 (36.6) | 47 (45.2) |
| Syringe coverage (median, IQR) | 0 (0–0) | 0.35 (0.09–0.67) | 0.39 (0.09–0.83) |
| Share injection equipment | |||
| Yes | 51 (47.2) | 27 (24.8) | 22 (23.9) |
| No | 57 (52.8) | 82 (75.3) | 70 (76.1) |
| Reuse syringes | |||
| Yes | 93 (94.9) | 89 (80.9) | 76 (78.4) |
| No | 5 (5.10) | 21 (19.1) | 21 (21.6) |